negative regulation of leukocyte activation
Definition
Target type: biologicalprocess
Any process that stops, prevents, or reduces the frequency, rate, or extent of leukocyte activation. [GOC:add]
Negative regulation of leukocyte activation is a critical process that ensures appropriate immune responses and prevents excessive inflammation and tissue damage. It involves a complex interplay of signaling pathways and regulatory mechanisms that dampen or inhibit the activation of leukocytes, which are white blood cells responsible for immune defense.
Key aspects of negative regulation of leukocyte activation include:
1. **Inhibition of signaling pathways:** Upon activation, leukocytes receive signals from various stimuli, such as pathogens, cytokines, and chemokines. These signals trigger intracellular signaling cascades that ultimately lead to leukocyte activation. Negative regulation involves inhibiting these signaling pathways by blocking or deactivating key signaling molecules. For example, inhibitory receptors, such as CTLA-4 and PD-1, can bind to ligands on antigen-presenting cells, leading to the suppression of T cell activation.
2. **Production of inhibitory molecules:** Various inhibitory molecules are produced by cells to regulate leukocyte activation. For instance, cytokines like IL-10 and TGF-β have immunosuppressive effects, inhibiting the proliferation and activation of immune cells. Other inhibitory molecules, such as adenosine and prostaglandins, can also suppress inflammation and leukocyte activity.
3. **Induction of apoptosis:** In some cases, negative regulation of leukocyte activation involves inducing apoptosis, or programmed cell death, of activated leukocytes. This eliminates potentially harmful immune cells and prevents uncontrolled inflammation.
4. **Regulation of chemokine and cytokine production:** Leukocytes release chemokines and cytokines, which are signaling molecules that attract and activate other immune cells. Negative regulation can involve controlling the production of these chemokines and cytokines, thus limiting the recruitment and activation of additional leukocytes.
5. **Modulation of cellular adhesion:** Leukocytes need to adhere to blood vessels and tissues to migrate to sites of inflammation. Negative regulation can involve inhibiting the expression of adhesion molecules that mediate this process, limiting leukocyte migration and activation.
Overall, negative regulation of leukocyte activation is a tightly controlled process that ensures the appropriate balance between immune activation and suppression. It is essential for maintaining immune homeostasis, preventing autoimmune diseases, and promoting tissue repair. Disruptions in this delicate balance can lead to various inflammatory and autoimmune disorders.'
"
Proteins (1)
Protein | Definition | Taxonomy |
---|---|---|
G-protein coupled estrogen receptor 1 | A G-protein coupled estrogen receptor 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q99527] | Homo sapiens (human) |
Compounds (1)
Compound | Definition | Classes | Roles |
---|---|---|---|
1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta(c)quinolin-8-yl)ethanone | 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone: G-1 was able to induce both c-fos expression and proliferation in the ERalpha-negative/GPR30-positive SKBR3 breast cancer cells, the requirement for ERalpha expression in GPR30/EGFR signaling may depend on the specific cellular context of different tumor types | agonist |